Some workers at the Environmental Protection Agency (EPA) have received a letter from the agency warning them that they may face termination amid the Trump administration's efforts to scale back ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. As a physician of 40 years experience, I cannot believe the folly of the past two weeks. Avian influenza ("bird flu") is ...

In the words of The Carpenters', "We've Only Just Begun!," I hate the news. Yet, each day I make myself look to see what Donald Trump and his mighty pen have done. The convicted felon has pardoned ...

As the end of the tax year approaches, those who are employed or receiving a pension may find themselves on the receiving end of a potentially daunting HMRC letter. These letters, known as Simple ...

With the end of the tax year approaching, people who are employed or receiving a pension may find themselves on the receiving end of a seemingly intimidating HMRC letter. Known as Simple ...

(RTTNews) - Globus Medical (GMED), a musculoskeletal solutions company, Thursday agreed to acquire Nevro Corp. (NVRO), a medical device company, in an all-cash transaction. Under the terms of the ...

Globus Medical and Nevro Preliminary Full-Year 2024 Revenue Outlook: On January 8, 2025, Globus Medical announced preliminary 2024 net sales of $2.52 billion, an increase of 60.6% over prior year ...

Globus Medical said the purchase would increase its portfolio of musculoskeletal technologies, therefore enhancing its position in neuromodulation and chronic pain management. Nevro, with its ...

AUDUBON, Pa. and REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp ...

Globus Medical (NYSE:GMED) said it has agreed to buy Nevro (NVRO) through an all-cash deal with an equity value of around $250M. Under the deal, Globus Medical (NYSE:GMED) will buy all of Nevro's ...

Globus Medical has a 12 month low of $49.33 and a 12 month high of $94.93. Globus Medical ( NYSE:GMED – Get Free Report ) last issued its quarterly earnings data on Tuesday, November 5th.